PDCD1 and cancer: To evade host immune surveillance, cancer cells can inhibit the immune system through inhibitory pathways such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or programmed-cell death 1 (PD-1) and its ligand (PD-L1).